Keyphrases
2-cycles
25%
5-fluorouracil (5-FU)
50%
Adenocarcinoma
25%
After Surgery
25%
Barrett's Adenocarcinoma
50%
Barrett's Carcinoma
100%
Biopsy Specimen
25%
Caldesmon
75%
Cancer Patients
25%
Chemotherapy
100%
Cisplatin
25%
Dihydropyrimidine Dehydrogenase
25%
Drug Resistance Gene
25%
ELF3
25%
ERCC1
25%
ERCC4
50%
Esophageal Adenocarcinoma
25%
Esophageal Squamous Cell Carcinoma
25%
Esophageal Tumor
25%
Esophagectomy
25%
Expression Level
50%
Expression Profile
25%
Formalin-fixed
25%
GADD45A
25%
Gene Expression
50%
Gene Expression Pattern
25%
Genetic Expression Profile
25%
Human Epidermal Growth Factor Receptor 2 (HER2)
50%
Intratumoral Heterogeneity
25%
Locally Advanced
75%
MAP7
25%
Metabolism-related Genes
25%
Methylenetetrahydrofolate Reductase (MTHFR)
100%
MRNA Level
50%
Multidrug Resistance Protein 1 (MDR1)
100%
Neoadjuvant Chemotherapy
25%
Paclitaxel
25%
Paraffin Embedding
25%
Real-time Reverse Transcriptase PCR
25%
Relevant Genes
25%
Resection Specimen
25%
Response to Chemotherapy
25%
Response to Neoadjuvant Chemotherapy
100%
Survival Benefit
25%
Taxanes
25%
Thymidine Phosphorylase
25%
Thymidylate
25%
Tumor Area
25%
Tumor Biopsy
25%
Tumor Tissue
25%
Medicine and Dentistry
Adenocarcinoma
100%
Biopsy Technique
25%
Caldesmon
75%
Carcinoma
100%
Cisplatin
25%
Dihydropyrimidine Dehydrogenase
25%
Esophageal Adenocarcinoma
25%
Esophagectomy
25%
Esophagus
25%
Esophagus Tumor
25%
Fluorouracil
50%
Formaldehyde
25%
Gene Expression
100%
Messenger RNA
25%
Methylenetetrahydrofolate Reductase
25%
Multidrug Resistance
25%
Multidrug Resistance Associated Protein 1
100%
Neoadjuvant Chemotherapy
100%
Neoplasm
50%
Paclitaxel
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Thymidine Phosphate
25%
Thymidine Phosphorylase
25%
Tumor Biopsy
25%
Pharmacology, Toxicology and Pharmaceutical Science
5,10 Methylenetetrahydrofolate Reductase (FADH2)
20%
Adenocarcinoma
80%
Caldesmon
60%
Carcinoma
100%
Chemotherapy
100%
Cisplatin
20%
Dihydropyrimidine Dehydrogenase
20%
Esophageal Adenocarcinoma
20%
Esophagus Tumor
20%
Fluorouracil
40%
Formaldehyde
20%
Malignant Neoplasm
20%
Messenger RNA
20%
Multidrug Resistance
20%
Multidrug Resistance Associated Protein 1
80%
Neoplasm
40%
Paclitaxel
20%
RNA Directed DNA Polymerase
20%
Taxane
20%
Thymidine Phosphate
20%
Thymidine Phosphorylase
20%
Biochemistry, Genetics and Molecular Biology
Caldesmon
75%
Cisplatin
25%
Dihydropyrimidine Dehydrogenase
25%
ERCC1
25%
Esophagus
25%
Fluorouracil
50%
Gene Expression
100%
Messenger RNA
25%
Metabolic Pathway
25%
Methylenetetrahydrofolate Reductase
25%
Multidrug Resistance
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
RNA
25%
Thymidine Monophosphate
25%
Thymidine Phosphorylase
25%
Immunology and Microbiology
Esophagus
25%
Gene Expression
100%
Multidrug Resistance
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%